This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Treatment of heart attack patients depends on history of cancer
Read more
Performance of Masimo acoustic respiration rate and Nellcor Plethysmographic respiration rate in volunteers compared
Read more
Once-daily single inhaler triple therapy receives positive opinion for appropriate patients with COPD
Read more
New two-year data for guselkumab following positive CHMP opinion
Read more
Masimo PVi® evaluated as part of goal-directed fluid therapy during bariatric surgery
Read more
Dubai Health Authority implements Masimo Patient SafetyNet™
Read more
Masimo SpHb® in trauma patients with low haemoglobin levels
Read more
Simple blood test opens door to new treatments for lung cancer patients
Read more
Romosozumab ARCH study results published in the New England Journal of Medicine
Read more
Results of Phase III CONVERT study of ALIS in treatment-refractory NTM lung disease announced
Read more
Masimo iSpO2® Rx Smart Device-Paired Pulse Oximeter evaluated in screening newborns for CCHD
Read more
Study evaluates utility of Masimo SpHb® during high-blood loss oncosurgery
Read more
Radiometer sponsored World Sepsis Day 2017
Read more
Eluxadoline receives final approval from NICE for the treatment of IBS with diarrhoea
Read more
Tivozanib now licensed in the European Union for first-line treatment
Read more
NICE decision following EU licensing for Kisqali awaited
Read more
Survival results from carfilzomib Phase III head-to-head trial published
Read more
Page 132 of 201
« First
«
...
10
20
30
...
130
131
132
133
134
...
140
150
160
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
x
Search for: